Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS ...

A compound normally associated with red blood cells may also play a game-changing antioxidant role in the brain, a study has ...

Did you know the same protein that gives blood its red color and carries oxygen throughout the body is also present inside ...

After three long months, on Aug. 18, Nesbit's Lanes held a celebration marking its grand reopening. Now, a fundraiser for ...

United States of America's Miss Ohio 2025 Tamera Carter will join hundreds of walkers and community partners on Sept. 14 to ...

Scientists have created a lifelike model of Amyotrophic Lateral Sclerosis (ALS), a type of motor neuron disease, using cells ...

Many people will never know the last time they will do certain things in life. Even though he navigates sometimes trying days ...

Primary lateral sclerosis (PLS) and amyotrophic lateral sclerosis (ALS) are neurodegenerative diseases. PLS typically develops slowly, while ALS rapidly affects mobility and can become fatal.

Familial amyotrophic lateral sclerosis (ALS) is an uncommon form of ALS that occurs due to an inherited gene. The disease causes motor neurons to die, which can lead to progressive muscle weakness.

• Key Amyotrophic Lateral Sclerosis Pipeline Therapies: ION363, FB418, SRK-015, RNS60, QRL-201, SAR443820, MN-166, VM202, VRG-50635, Zilucoplan, and others.

Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. The amyotrophic ...